Wells Fargo
EOLS icon

Wells Fargo’s Evolus EOLS Stock Holding History

Wells Fargo’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$306K Sell
74,497
-1,471
-2% -$7.13K ﹤0.01% 4435
2025
Q4 		$505K Buy
75,968
+27,811
+58% +$188K ﹤0.01% 4491
2025
Q3 		$296K Buy
48,157
+6,336
+15% +$49.4K ﹤0.01% 4695
2025
Q2 		$385K Sell
41,821
-7,417
-15% -$75.9K ﹤0.01% 4334
2025
Q1 		$592K Sell
49,238
-109
-0.2% -$1.43K ﹤0.01% 3973
2024
Q4 		$545K Buy
49,347
+14,506
+42% +$204K ﹤0.01% 4121
2024
Q3 		$564K Buy
34,841
+11,361
+48% +$159K ﹤0.01% 3918
2024
Q2 		$255K Buy
23,480
+8,440
+56% +$104K ﹤0.01% 4346
2024
Q1 		$211K Buy
15,040
+1,568
+12% +$20.4K ﹤0.01% 4438
2023
Q4 		$142K Sell
13,472
-454
-3% -$4.06K ﹤0.01% 4685
2023
Q3 		$127K Sell
13,926
-44,333
-76% -$398K ﹤0.01% 4637
2023
Q2 		$424K Buy
58,259
+46,757
+407% +$403K ﹤0.01% 4070
2023
Q1 		$97.3K Buy
11,502
+5,859
+104% +$53K ﹤0.01% 4819
2022
Q4 		$42.4K Buy
5,643
+743
+15% +$5.75K ﹤0.01% 4943
2022
Q3 		$39K Sell
4,900
-3,532
-42% -$37.4K ﹤0.01% 5062
2022
Q2 		$98K Sell
8,432
-9,681
-53% -$114K ﹤0.01% 4646
2022
Q1 		$203K Sell
18,113
-9,785
-35% -$83.4K ﹤0.01% 4970
2021
Q4 		$182K Sell
27,898
-32,865
-54% -$225K ﹤0.01% 5315
2021
Q3 		$462K Buy
60,763
+40,697
+203% +$421K ﹤0.01% 4709
2021
Q2 		$253K Buy
20,066
+6,549
+48% +$72K ﹤0.01% 4928
2021
Q1 		$176K Sell
13,517
-42,259
-76% -$390K ﹤0.01% 5214
2020
Q4 		$187K Buy
55,776
+28,553
+105% +$107K ﹤0.01% 5115
2020
Q3 		$107K Sell
27,223
-17,593
-39% -$64.3K ﹤0.01% 5236
2020
Q2 		$237K Sell
44,816
-11,461
-20% -$52.8K ﹤0.01% 4809
2020
Q1 		$234K Buy
56,277
+4,971
+10% +$42.1K ﹤0.01% 4587
2019
Q4 		$624K Buy
51,306
+17,470
+52% +$246K ﹤0.01% 4191
2019
Q3 		$529K Buy
33,836
+13,148
+64% +$215K ﹤0.01% 4335
2019
Q2 		$303K Sell
20,688
-11,100
-35% -$220K ﹤0.01% 4727
2019
Q1 		$717K Buy
31,788
+19,131
+151% +$414K ﹤0.01% 4115
2018
Q4 		$150K Buy
12,657
+6,713
+113% +$95.7K ﹤0.01% 5085
2018
Q3 		$110K Buy
5,944
+5,325
+860% +$115K ﹤0.01% 5317
2018
Q2 		$17K Sell
619
-171
-22% -$3.02K ﹤0.01% 5851
2018
Q1 		$7K Buy
+790
New +$9.04K ﹤0.01% 6002

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wells Fargo's EOLS Position: Q1 2026 in Review

Wells Fargo reduced its Evolus (EOLS) stake by 1.9% in Q1 2026, selling an estimated $7.13K and leaving 74,497 shares worth $306K. The position accounts for ﹤0.01% of the portfolio, ranked #4435.

Wells Fargo first reported a position in EOLS in Q1 2018 and has held it in 33 quarters since. The position peaked at $717K in Q1 2019. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • Wells Fargo held 74,497 shares of Evolus worth $306K as of Q1 2026.
  • Wells Fargo sold 1,471 Evolus shares in Q1 2026, an estimated $7.13K.
  • Evolus made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4435 holding.
  • Wells Fargo first reported a position in Evolus in Q1 2018 and has held it in 33 quarters since.
  • Wells Fargo's Evolus position peaked at $717K in Q1 2019.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.